Correlation Between Bioatla and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bioatla and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and AN2 Therapeutics, you can compare the effects of market volatilities on Bioatla and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and AN2 Therapeutics.
Diversification Opportunities for Bioatla and AN2 Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bioatla and AN2 is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Bioatla i.e., Bioatla and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Bioatla and AN2 Therapeutics
Given the investment horizon of 90 days Bioatla is expected to under-perform the AN2 Therapeutics. In addition to that, Bioatla is 1.26 times more volatile than AN2 Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.21 per unit of volatility. If you would invest 110.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bioatla vs. AN2 Therapeutics
Performance |
| Timeline |
| Bioatla |
| AN2 Therapeutics |
Bioatla and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bioatla and AN2 Therapeutics
The main advantage of trading using opposite Bioatla and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |